Received Aug 14, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | UNK | — |
Pain in arm; Flu symptoms; Muscle ache; This non-serious case was reported by a consumer via call center representative and described the occurrence of pain in arm in a male patient who received Herpes zoster (Shingrix) for prophylaxis. In MAR-2022, the patient received the 1st dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced pain in arm (Verbatim: Pain in arm), flu symptoms (Verbatim: Flu symptoms) and muscle pain (Verbatim: Muscle ache). The outcome of the pain in arm, flu symptoms and muscle pain were unknown. It was unknown if the reporter considered the pain in arm, flu symptoms and muscle pain to be related to Shingrix. It was unknown if the company considered the pain in arm, flu symptoms and muscle pain to be related to Shingrix. Additional Information: GSK Receipt Date: 05-AUG-2025 The reporter was the patient who stated that he received his first dose of Shingrix in March 2022. The patient had experienced a painful arm, flu symptoms, and muscle ache after the dose. Due to these side effects, he decided not to get another dose until 05th August 2025.